A high ratio of tamoxifen metabolite E to tamoxifen is associated with an increased risk of breast cancer recurrences in premenopausal women

被引：0
|
作者：
Johanning, Janina
Eccles, Diana M.
Eccles, Bryony
Eichelbaum, Michel
Schwab, Matthias
Brauch, Hiltrud
Mordter, Thomas
Schroth, Werner
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2029
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2029
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Factors Associated with Lack of Tamoxifen Initiation in Young Women at High-risk for Breast Cancer
    Rizk, N. N.
    Dokic, D.
    Kochkodan, J.
    Estevez, S.
    Singh, H.
    Yanik, M.
    Jeruss, J. S.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S45 - S46
  • [32] AGR2, an estrogen response gene associated with tamoxifen resistance, is modulated by acolbifene in premenopausal women at high risk for development of breast cancer
    Fabian, Carol J.
    Phillips, Teresa A.
    Kimler, Bruce F.
    CANCER RESEARCH, 2022, 82 (04)
  • [33] Tamoxifen Infrequently Used by Women at Risk for Breast Cancer
    不详
    CA-A CANCER JOURNAL FOR CLINICIANS, 2010, 60 (04) : 204 - 206
  • [34] Tamoxifen for breast cancer risk reduction: Is it acceptable to women at risk?
    Melnikow, J
    Paterniti, D
    Jim, N
    Kuenneth, C
    Birch, S
    Kuppermann, M
    Azari, R
    DeGregorio, M
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 303 - 304
  • [35] Is ERα a Tamoxifen Predictive Factor in ERα Negative Breast Cancer in Premenopausal Women?
    Kallstrom, A-C
    Ferno, M.
    Jonsson, P. E.
    Landberg, G.
    Nordenskjold, B.
    Stal, O.
    CANCER RESEARCH, 2010, 70
  • [36] Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancer
    Borner, MM
    Bacchi, M
    Castiglione, M
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (12) : 2173 - 2176
  • [37] Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women
    Love, Richard R.
    Dinh, Nguyen Van
    Quy, Tran Tu
    Linh, Nguyen Dieu
    Tung, Nguyen Dinh
    Shen, Tien-zhen
    Hade, Erinn M.
    Young, Gregory S.
    Jarjoura, David
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 253 - 257
  • [38] Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer
    Ryu, Ki-Jin
    Kim, Min Sun
    Lee, Ji Yoon
    Nam, Seunghyun
    Jeong, Hye Gyeong
    Kim, Tak
    Park, Hyuntae
    JAMA NETWORK OPEN, 2022, 5 (11) : E2243951
  • [39] Survival with adjuvant surgical oophorectomy and tamoxifen in premenopausal women with operable breast cancer
    Love, R. R.
    Dinh, N. V.
    Quy, T. T.
    Linh, N. D.
    Hade, E. M.
    Young, G. S.
    Jarjoura, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer
    Shushan, A
    Peretz, T
    Uziely, B
    Lewin, A
    MorYosef, S
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (01) : 141 - 144
12345